Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study

Author(s):
Creemers-Schild, D.; Kroon, F.P.; Kuijper, E.J.; Boer, M.G.J. de
Published
2016
Publication type
Article / Letter to editor

Abstract

We observed high cure rates of PCP by treatment with intermediate-dose TMP-SMX. In addition, a step-down strategy to low-dose TMP-SMX during treatment in selected patients appears to be safe and does not compromise the outcome of treatment.

Pneumocystis jiroveciiTreatmentLow doseCotrimoxazoleTrimethoprim-sulfamethoxazoleAntibiotic stewardship
Date issued
2016-06-01
Language
English
Publisher
SPRINGER HEIDELBERG
Is part of
Infection (2016), Vol. 44, no. 3, p. 291-299
hdl
1887/99330
doi
10.1007/s15010-015-0851-1